166 related articles for article (PubMed ID: 38399404)
41. Anti-inflammatory and antiproliferative compounds from Sphaeranthus africanus.
Tran HT; Gao X; Kretschmer N; Pferschy-Wenzig EM; Raab P; Pirker T; Temml V; Schuster D; Kunert O; Huynh L; Bauer R
Phytomedicine; 2019 Sep; 62():152951. PubMed ID: 31136898
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
43. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
44. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
[TBL] [Abstract][Full Text] [Related]
45. Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow.
Ulbrich H; Soehnlein O; Xie X; Eriksson EE; Lindbom L; Albrecht W; Laufer S; Dannhardt G
Biochem Pharmacol; 2005 Jul; 70(1):30-6. PubMed ID: 15894291
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
[TBL] [Abstract][Full Text] [Related]
48. Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma.
Bošković J; Dobričić V; Keta O; Korićanac L; Žakula J; Dinić J; Jovanović Stojanov S; Pavić A; Čudina O
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931946
[TBL] [Abstract][Full Text] [Related]
49. Discovery of polymethoxyflavones as potential cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX) and phosphodiesterase 4B (PDE4B) inhibitors.
Md Idris MH; Mohd Amin SN; Mohd Amin SN; Wibowo A; Zakaria ZA; Shaameri Z; Hamzah AS; Selvaraj M; Teh LK; Salleh MZ
J Recept Signal Transduct Res; 2022 Aug; 42(4):325-337. PubMed ID: 34323638
[TBL] [Abstract][Full Text] [Related]
50. Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.
Pervaiz A; Jan MS; Hassan Shah SM; Khan A; Zafar R; Ansari B; Shahid M; Hussain F; Ijaz Khan M; Zeb A; Mukarram Shah SM
J Biomol Struct Dyn; 2022 May; ():1-14. PubMed ID: 35507043
[TBL] [Abstract][Full Text] [Related]
51. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
[TBL] [Abstract][Full Text] [Related]
52. Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
Moussa G; Alaaeddine R; Alaeddine LM; Nassra R; Belal ASF; Ismail A; El-Yazbi AF; Abdel-Ghany YS; Hazzaa A
Eur J Med Chem; 2018 Jan; 144():635-650. PubMed ID: 29289887
[TBL] [Abstract][Full Text] [Related]
53. Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases.
Yarla NS; Pathuri G; Gali H; Terzyan S; Panneerselvam J; Chandrakesan P; Scotti MT; Houchen C; Madka V; Rao CV
J Inflamm Res; 2020; 13():1261-1278. PubMed ID: 33408499
[TBL] [Abstract][Full Text] [Related]
54. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
[TBL] [Abstract][Full Text] [Related]
55. In vitro, in vivo and in silico evaluation of analgesic, anti-inflammatory, and anti-pyretic activity of salicylate rich fraction from Gaultheria trichophylla Royle (Ericaceae).
Alam F; Hanif M; Rahman AU; Ali S; Jan S
J Ethnopharmacol; 2023 Jan; 301():115828. PubMed ID: 36240979
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
57. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
58. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
[TBL] [Abstract][Full Text] [Related]
59. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J
Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]